Position in DNLI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19,958
+$3,331 QoQ
Shares Held
776
-10.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#224
of 290 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Optiver Holding B.V. holds $14,292,933 across 180 Biotechnology names. DNLI ranks #46 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
76,368 | $10,176,799 | |
| 2 | TECH |
BIO-TECHNE Corp
|
8,493 | $600,030 | |
| 3 | NBTX |
Nanobiotix S.A.
|
13,631 | $513,888 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
652 | $323,867 | |
| 5 | BNTX |
BioNTech SE
|
2,150 | $200,057 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
22,559 | $197,504 | |
| 7 | ARGX |
Argenx SE
|
174 | $161,431 | |
| 8 | VNDA |
Vanda Pharmaceuticals Inc.
|
18,089 | $110,704 |
All Filings in DNLI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,958 | 776 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $16,627 | 866 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,752 | 409 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,009 | 896 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $12,493 | 893 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $421 | 31 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||